Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

European Research Council grant · Running

STOP-OR-GO Unraveling the network that controls the fate of RNA Polymerase II during early elongation.

Coordinator
Universiteit Utrecht, Netherlands
Runs
1 January 2026 to 31 December 2030
Status
Running
EU funding
€1.5m
Total cost
€1.5m
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101221791

What the project is doing

In the project's own words, from its summary on CORDIS.

The repertoire of messenger RNAs (mRNAs) in a cell dictates cell identity and function. Therefore, mRNA expression is tightly controlled. A previously underappreciated regulatory step is early transcription termination, which can abort the synthesis of full-length mRNAs. The early termination of many non-coding RNAs prevents transcriptional interference and genomic instability. Thus, cells need to correctly balance early termination and productive elongation at both coding and non-coding loci.

Why elongation is favoured at some loci, and termination at others, is poorly understood. To understand how the balance between elongation and termination is achieved, we need to know what sequence elements and proteins are involved, and how they work together. These regulatory sequences and proteins have not been systematically identified. Using INSERT-seq, I have identified novel candidate regulators that I will study here in more detail.

The same reporter setup will be adapted to identify novel trans-acting regulators of the elongation/termination balance. These approaches act synergistically to uncover the network of regulators. I will then apply a combination of unbiased and hypothesis-driven experiments to understand the mechanisms of regulation. We will also focus on understanding how early termination is promoted by ZC3H4 (Restrictor), a recently identified suppressor of non-coding RNAs.

The work proposed here will uncover the principles that decide if transcription of a locus will terminate early, an essential step towards fully understanding transcription regulation. Knowing the sequence and protein regulators that determine the fate of early elongating RNAPII will open opportunities to study how disease mutations affect their function. Moreover, understanding the control of this elongation/termination balance will also provide us with tools to manipulate this balance.

This will improve our ability to design sequences for optimal transgene expression in gene therapy.

Topics

Who is involved

OrganisationCityCountryRole
Universiteit UtrechtUtrechtNetherlandsCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI